NZ197164A - Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride - Google Patents
Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychlorideInfo
- Publication number
- NZ197164A NZ197164A NZ197164A NZ19716481A NZ197164A NZ 197164 A NZ197164 A NZ 197164A NZ 197164 A NZ197164 A NZ 197164A NZ 19716481 A NZ19716481 A NZ 19716481A NZ 197164 A NZ197164 A NZ 197164A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- composition according
- aluminum
- weight
- antiperspirant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Description
New Zealand Paient Spedficaiion for Paient Number 1 97164
197164
Prserity Datcfs): ;.§9..
CotnpSete Specification FiSsd: 7-Ciass:
. ubHcatior. Date: ...
Pf\Q. Journal, !Mo:
No.:
Date:
NEW ZEALAND
PATENTS ACI, 1953
COMPLETE SPECIFICATION
ANTIPERSPIRANT COMPOSITION CONTAINING AS ACTIVE ANTIPERSPIRANT AGENTS AN ALUMINUM CHLORIDE AND AN ALUMINUM
ZIRCONIUM KYDROXYCHLORIDE
Jf/We, BRISTOL-MYERS COMPANY, a State of Delaware corporation having offices at 345 Park Avenue, New York, New York, United States of America,
hereby declare the invention for which }£ / we pray that a patent may be granted to me/us, and the method by which it is to be performed, to be particularly described in and by the following statement:-
(followed by la)
- la -
ANTIPERSPIRANT COMPOSITION CONTAINING AS ACTIVE ANTIPERSPIRANT AGENTS AN ALUMINUM CHLORIDE
AND AN ALUMINUM ZIRCONIUM HYDROXYCHLORIDS
This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspirant compositions containing as active ingredients a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychloride individually as antiperspirant materials. We have now found, however, when these materials are employed together they act synergis-tically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containing a carrier and as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more detailed objects of this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the composition .
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel responding to any one given material. However, when the combination of active ingredients of this invention was used over 93% of the panel participants responded favorably. Additionally,
197164
surprisingly high activities were recorded; 88% had superior activity. It has always been believed that the activity mechanism for different salts differ. What has been discovered here is a combination product that allows activity 5 responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solution is very acidic. We have also found that raising the pH alone is not enough to alleviate the irritation response. 10 However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat, however, it can be essentially eliminated 15 completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may 20 vary somewhat. For the most part, they will constitute between substantially 5 and substantially 25% by weight based on the total weight of the composition and preferably 7.5% to about 15% by weight. As used herein, the term "an aluminum chloride" is intended to refer to anhydrous aluminum chloride as well 25 as its hydrated and hydroxide forms e.g. AlCl^ • 6^0 or
Al2(OH) CI.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and be described by the general formula:
Al . Z 0 (OH) . . CI x H_0
4 n 14-n n 2
wherein n has the value 0 to 14 and x has the value of from 0 to 20. By way of example, mention may be made of compounds
PATENT OFRCf
18 MAR 1983
PECEIVEO
i n.
197164
of formulas:
Al4 ZrO (OH)X1 Cl3 ; and
Al ZrO (OH)Cl^ and their corresponding hydrates.
The amount of the aluminum zirconiiam hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between -substantially 2% to substantially 20% by weight based on the total weight of the composition and preferably between about 5% to about 10%.
An important feature of the present compositions is the ratio of the aluminum salt and the and the aluminum zirconium salt that they contain-. Thi"5 ratio■ will—be--in—the range of from substantially 0.5 to substantially 2; the preferred range being from about 1.2 5 to about 1.75.
Another important relationship in the present compositions is the aluminum plus zirconium metal:chloride mole ratio. It is important that this be less than .9 to retain the ionic character of the complex which is related to its antiperspirant activity.
As indicated previously, it is highly advantageous to use a combination of magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combination will ordinarily be used to adjust the pH in the range of from about 2.5 to about 4.5. The glycine will be employed at a level of from substantially 0.25% to substantially 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or-oxide) will constitute substantially 1% to substantially 9%. The ratio of glycine to magnesium hydroxide (or oxide) is also an important factor. This ratio may be in the range of from.about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1.0.
The novel combination of antiperspirant materials and the pH adjusting agents described above may be incorporated
'v;^A'f£MT omci
18 MAR J983
in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a suitable solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials:
A. Roll-On (Lotions and Creams)
Actives 25%
Emollients 2-4%
Surface active agents 2-4%
Buffering systems 2-7% Water q.s. 100%
B. Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams
Actives
%
Emollients
-15%
Suspending agents
2-5%
Buffering agents
2-4%
Water q.s. 100%
Aerosol Above 70-85% Propellant 15-30%
Sticks
Actives
%
Gelling agent ro 1
Waxes
-20%
Emollients
-20%
Buffering agents ro •
•£»
Of
Externalphase q.s. 100%
* Anhydrous solvent
The following Examples are given to further illustrate the present invention. It is understood, however, that the invention is not limited thereto.
EXAMPLE 1 Roll-On Lotion (Emulsion o/w)
% by Wt.
AlCl . 6H20 15.00
Mg(OH)~ 3.75
1
Al/Zr trichlorohydrate 10.00
Brij 72 (Polyoxyethylene
2 Stearyl Ether) 3.00
Brij 78 (Polyoxyethylene
Stearyl Ether) 1.00
Glycine 0.50
Disodium EDTA 0.10
Polyoxypropylene 15
Stearyl Ether (Arlamol E) 4.00
H20 62.65
100.00
EXAMPLE 2 Clear Water Solution (Pump Spray)
A1C13 . 6H20 15.00
Mg(OH)2 3.75
Glycine 0.50
Al/Zr trichlorohydrate^" 10.00
H20 65.75
Proce.tyl AWS (PPG-5 Cetheth 20) 5.00
100.00
EXAMPLE 3 Aerosol Antiperspirant
Al/Complex Powder2 6.00
Al/Zr trichlorohydrate"^ 4.00
Dibutyl phthalate 11.00
Al4ZrO(OH)11Cl3
Product prepared by spray drying A1C1-; M (OH)_ and glycine in the weight ratio of 4:1: .5 ^
EXAMPLE 3 (Cont'd)
Cabosil M-5 0.30
Bentone 34 0.10
Isobutane 78.60
100.00
EXAMPLE 4 Stick Antiperspirant
Al/Complex Powder 15.00
Al/Zr trichlorohydrate 10.00
Stearyl alcohol 20.00
Dibutyl phthalate 41.00
Procetyl AWS (PPG-5 Cetheth 20) 10.00
Montan wax 4.00
100.00
To demonstrate the fact that the combination of the aluminum chloride and the aluminum zirconiiam hydroxychloride act synergistically as antiperspirants, three compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiperspirant material. Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B contained 10% by weight of aluminum zirconiiam hydroxychloride and 15% by weight of aluminum chloride; and Composition C contained 25% by weight of aluminum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel. The procedure employed was as described in Federal Register, Vol. 43, Number 196, October 10, 1978 and is called the Gravemetric Axillary Antiperspirant Test.
The results of this test are summarized in Table I below which gives the formulas of Compositions A, B and C
O c77 ^ ^ £■' I \.
as well as the antiperspirant activity measured for each composition.
TABLE I
B
Aluminum Zirconium hydroxide Complex 25 10 —
Aluminum Chloride — 15 25
Emollient 2-4 2-4 2-4
Surface Active Agents 2-4 2-4 2-4
q.s. buffer to pH 3.2 + .3
q.s. water to 100%
pH at time of test 3.5 3.2 3.4
Activity 50% 62% 53%
As will be seen from the above Table, a 20-25% enhancement of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing from the spirit of this invention.
197164
Claims (11)
1. An antiperspirant composition comprising a carrier and as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride, said composition comprising, based on the total weight of the composition, from substantially 5% to substantially 25% by weight of an aluminum chloride and from substantially 2% to substantially 20% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to aluminum zirconium salt in said composition being in the range of from substantially 0.5 to substantially 2 and the mole ratio of aluminium plus zirconium metal to chloride being less than .9.
2. A composition according to Claim 1 including as a pH adjusting agent a combination of magnesium hydroxide or oxide and glycine, said magnesium hydroxide or oxide constituting from substantially 1% to substantially 9% by weight of said composition and said glycine constituting from substantially 0.25% to substantially 5% by weight of said composition.
3. A composition according to Claim 1 or Claim 2 in the form of a lotion.
4. A composition according to Claim 1 or Claim 2 in the form of a solution.
5. A composition according to Claim 1 or Claim 2 in the form of a stick.
6. A composition according to Claim 1 or Claim 2 in the form of an aerosol < composition.
7. A composition according to Claim 1 or Claim 2 in the form of a pump spray composition.
8. A composition according' to Claim 1 or Claim 2 in the form of a cream or a gel. 9 . A composition according to Claim 1 or Claim 2 in the form of a foam. 'i.Z P'ATcOT OFFICB 18 MAR 1983 I
9 - 197164
10. A composition according to Claim 2, whenever formulated in accordance with the formula A, B or C hereinbefore described.
11. A composition according to Claim 1 or Claim 2, substantially as hereinbefore described with particular reference to any one of the foregoing Examples. DATED THIS DAY OF 19-PZ/ A. J. PARK & SON PE.l $ ~S- AGENTS FOR THE APPLICANTS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15311380A | 1980-05-27 | 1980-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ197164A true NZ197164A (en) | 1984-08-24 |
Family
ID=22545825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ197164A NZ197164A (en) | 1980-05-27 | 1981-05-21 | Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5711908A (en) |
AU (1) | AU547530B2 (en) |
BE (1) | BE888975A (en) |
CA (1) | CA1140470A (en) |
CH (1) | CH644755A5 (en) |
DE (1) | DE3120742A1 (en) |
FR (1) | FR2483230A1 (en) |
GB (1) | GB2076289B (en) |
GR (1) | GR75643B (en) |
IT (1) | IT1170993B (en) |
MX (1) | MX156358A (en) |
NL (1) | NL8102540A (en) |
NZ (1) | NZ197164A (en) |
PH (1) | PH16329A (en) |
PT (1) | PT73090B (en) |
SE (1) | SE452107B (en) |
ZA (1) | ZA813484B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1153313A (en) * | 1980-12-15 | 1983-09-06 | Chung T. Shin | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
US4774079A (en) * | 1980-12-15 | 1988-09-27 | Bristol-Myers Company | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
US4606915A (en) * | 1981-04-23 | 1986-08-19 | Bristol-Myers Company | Antiperspirant combination containing an aluminum halohydrate and a stannic halide |
US4775528A (en) * | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
US5114705A (en) * | 1983-08-16 | 1992-05-19 | The Gillette Company | Antiperspirant composition |
US5589196A (en) * | 1983-08-16 | 1996-12-31 | The Gillette Company | Antiperspirant composition |
GB2144992A (en) * | 1983-08-16 | 1985-03-20 | Gillette Co | Antiperspirants |
US4673570A (en) * | 1985-03-20 | 1987-06-16 | Carter-Wallace, Inc. | Gelled antiperspirant compositions |
JPH05112440A (en) * | 1991-08-09 | 1993-05-07 | Sayuri Takemoto | Coating agent for deodorization |
US6136302A (en) * | 1999-02-18 | 2000-10-24 | The Procter & Gamble Company | Process of making zirconium-aluminum antiperspirant active |
US6375937B1 (en) | 2000-10-20 | 2002-04-23 | Colgate-Palmolive Company | Antiperspirant salts for enhanced cosmetic products |
FR2828646B1 (en) † | 2001-08-17 | 2004-11-26 | Oreal | ANHYDROUS ANTITRANSPIRANT STICK |
US20040109833A1 (en) | 2002-12-09 | 2004-06-10 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
US7905673B2 (en) | 2003-11-17 | 2011-03-15 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
CA2785448C (en) * | 2009-12-23 | 2014-10-14 | Colgate-Palmolive Company | Method of making an anhydrous liquid antiperspirant composition |
BR112016010562B1 (en) * | 2013-11-18 | 2019-12-31 | Colgate Palmolive Co | aqueous composition and use of disodium edta as a preservative in an antiperspirant composition |
BR112017010098B1 (en) | 2014-12-15 | 2020-12-29 | Unilever Nv | antiperspirant composition |
US9572758B2 (en) | 2015-06-30 | 2017-02-21 | Gulbrandsen Technologies, Inc. | Method of making high performance activated aluminum sesquichlorohydrate powders |
BR102016026099B1 (en) * | 2015-11-09 | 2021-09-28 | Gulbrandsen Technologies, Inc | ACTIVE ANTI-TRANSPIRING SOLUTION, TOPIC COMPOSITION, AND, METHOD TO REDUCE HUMAN SKIN TRANSPIRATION AND PROVIDE ANTI-BACTERIAL ACTIVITIES |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2906668A (en) * | 1955-06-13 | 1959-09-29 | Reheis Company Inc | Zirconyl and aluminum halohydroxy complex |
US3903258A (en) * | 1973-08-06 | 1975-09-02 | Gillette Co | Zirconium aluminum complexes and method of making the same |
US3981986A (en) * | 1973-11-23 | 1976-09-21 | Armour Pharmaceutical Company | Zirconium-aluminum-polyol buffered anti-perspirant complexes |
US4017599A (en) * | 1973-11-23 | 1977-04-12 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with salts of amino acids |
AU8303275A (en) * | 1974-07-17 | 1977-01-20 | Armour Pharma | Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals |
JPS5454863A (en) * | 1977-10-03 | 1979-05-01 | Kubota Ltd | Stalk and straw conveying apparatus with safety cover |
-
1980
- 1980-07-09 CA CA000355786A patent/CA1140470A/en not_active Expired
-
1981
- 1981-05-21 NZ NZ197164A patent/NZ197164A/en unknown
- 1981-05-21 AU AU70928/81A patent/AU547530B2/en not_active Ceased
- 1981-05-22 FR FR8110236A patent/FR2483230A1/en active Granted
- 1981-05-22 GR GR65041A patent/GR75643B/el unknown
- 1981-05-22 NL NL8102540A patent/NL8102540A/en not_active Application Discontinuation
- 1981-05-25 ZA ZA00813484A patent/ZA813484B/en unknown
- 1981-05-25 DE DE19813120742 patent/DE3120742A1/en active Granted
- 1981-05-25 IT IT48527/81A patent/IT1170993B/en active
- 1981-05-26 GB GB8116054A patent/GB2076289B/en not_active Expired
- 1981-05-26 MX MX187478A patent/MX156358A/en unknown
- 1981-05-26 BE BE0/204911A patent/BE888975A/en not_active IP Right Cessation
- 1981-05-26 CH CH345681A patent/CH644755A5/en not_active IP Right Cessation
- 1981-05-26 PT PT73090A patent/PT73090B/en unknown
- 1981-05-27 PH PH25676A patent/PH16329A/en unknown
- 1981-05-27 JP JP7944281A patent/JPS5711908A/en active Granted
- 1981-05-27 SE SE8103369A patent/SE452107B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX156358A (en) | 1988-08-12 |
JPS5711908A (en) | 1982-01-21 |
FR2483230A1 (en) | 1981-12-04 |
PT73090A (en) | 1981-06-01 |
PT73090B (en) | 1983-02-08 |
GR75643B (en) | 1984-08-02 |
CA1140470A (en) | 1983-02-01 |
DE3120742C2 (en) | 1988-10-27 |
JPS6412245B2 (en) | 1989-02-28 |
NL8102540A (en) | 1981-12-16 |
DE3120742A1 (en) | 1982-03-18 |
SE8103369L (en) | 1981-11-28 |
FR2483230B1 (en) | 1985-01-04 |
SE452107B (en) | 1987-11-16 |
GB2076289A (en) | 1981-12-02 |
IT8148527A0 (en) | 1981-05-25 |
PH16329A (en) | 1983-09-05 |
IT1170993B (en) | 1987-06-03 |
BE888975A (en) | 1981-11-26 |
GB2076289B (en) | 1985-01-09 |
CH644755A5 (en) | 1984-08-31 |
ZA813484B (en) | 1982-05-26 |
AU7092881A (en) | 1981-12-03 |
AU547530B2 (en) | 1985-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ197164A (en) | Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride | |
US4937069A (en) | Anhydrous semi-solid antiperspirant suspension | |
CA1172572A (en) | Antiperspirant composition | |
US4053581A (en) | Antiperspirant solution containing a mixture of substantially volatile and substantially non-volatile siloxane liquids | |
US4073880A (en) | Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid | |
EP3223914B1 (en) | Zinc phosphate complex | |
JP2004500306A (en) | Underarm cosmetic composition containing lower alkyl acetate | |
US20060067901A1 (en) | Antiperspirant compositions | |
US4215105A (en) | Anticalculus oral composition | |
WO2019206764A1 (en) | An antiperspirant composition | |
EP3586925B1 (en) | Zinc phosphate complex | |
EP3233207B1 (en) | Personal care compositions with zinc phosphate active | |
AU2022287610A1 (en) | An antiperspirant composition | |
US20220257480A1 (en) | An antiperspirant composition | |
US5135741A (en) | Antiperspirant product | |
EP3941594B1 (en) | An antiperspirant composition comprising reactive salts | |
US20230293400A1 (en) | An Antiperspirant Composition | |
EP3223779B1 (en) | Personal care composition with zinc phosphate active | |
US4490354A (en) | Antiperspirant method containing vanadium salts | |
US5194249A (en) | Non-whitening antiperspirant compositions | |
EP3941593B1 (en) | An antiperspirant composition comprising reactive salts | |
US4219540A (en) | Method for inhibiting perspiration | |
NZ199507A (en) | Antiperspirant compositions containing an aluminium halohydrate and a stannic halide | |
JP2018203683A (en) | Antiperspirant composition | |
US20220054374A1 (en) | An antiperspirant composition comprising inorganic polyionic cluster |